1. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed 2020; 9: 157–60.
2. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---16-march-2020 (accessed September 04, 2022)
3. Ritchie H, Mathieu E, Rodés-Guirao L, et al. "Coronavirus Pandemic (COVID-19)". Retrieved from: https://ourworldindata.org/coronavirus (accessed September 04, 2022)
4. Mercer T, Almond N, Chain P et al. A roadmap to better COVID-19 testing from the Coronavirus Standards Working Group. https://www.researchgate.net/publication/356371245_A_roadmap_to_better_COVID-19_testing_from_the_Coronavirus_Standards_Working_Group publication details to be added after provision by journal
5. International Organization for Standardization. Conformity assessment - general requirements for proficiency testing. ISO/IEC 17043:2010 ISO, Geneva, 2010.
6. Buchta C, Coucke W, Huf W, et al. External quality assessment providers' services appear to more impact the immunohaematology performance of laboratories than national regulatory and economic conditions. Clin Chem Lab Med 2022; 60: 361–9.
7. Buchta C, Müller MM, Griesmacher A. The importance of external quality assessment data in evaluating SARS-CoV-2 virus genome detection assays. Lancet Microbe 2022; 3: e168.
8. Kelly-Cirino CD, Nkengasong J, Kettler H, et al. Importance of diagnostics in epidemic and pandemic preparedness. BMJ Glob Health 2019; 4: e001179.
9. Braga F, Pasqualetti S, Panteghini M. The role of external quality assessment in the verification of in vitro medical diagnostics in the traceability era. Clin Biochem 2018; 57: 23–8.
10. https://www.ecdc.europa.eu/en/publications-data/ecdc-public-health-microbiology-strategy-2018-2022 (accessed September 04, 2022)
11. https://apps.who.int/iris/bitstream/handle/10665/342002/WHO-2019-nCoV-lab-testing-2021.1-eng.pdf?sequence=1&isAllowed=y (accessed September 04, 2022)
12. https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas (accessed September 04, 2022)
13. https://www.ecdc.europa.eu/en/covid-19/surveillance/testing-strategies (accessed September 04, 2022)
14. https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html (accessed September 04, 2022)
15. https://www.gov.uk/government/publications/how-tests-and-testing-kits-for-coronavirus-covid-19-work/guidance-for-manufacturers-diagnostic-assurance-with-sars-cov-2-variants-in-circulation (accessed September 04, 2022)
16. https://aslm.org/wp-content/uploads/2020/10/ReportQualityAssuranceCOVID2019-En-2020-07-06-Web.pdf?x80040 (accessed September 04, 2022)
17. https://www.theglobalfund.org/media/9628/covid19_interimqualityassurancerequirementsdiagnosticproducts_guidance_en.pdf (accessed September 04, 2022)
18. https://www.finddx.org/wp-content/uploads/2020/09/COVID-19-Testing-in-the-Laboratory-Sept2020.pdf (accessed September 04, 2022)
19. International Organization for Standardization. In vitro diagnostic test systems — Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods. ISO/TS 5798:2022; ISO, Geneva, 2022
20. Asai S, Seki A, Akai Y, et al. Nationwide external quality assessment of SARS-CoV-2 nucleic acid amplification tests in Japan. Int J Infect Dis 2022; 115: 86–92.
21. Buchta C, Görzer I, Chiba P, et al. Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR. Clin Chem Lab Med 2020; 59: 987–94.
22. Buchta C, Camp JV, Jovanovic J, et al. The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria. Clin Chem Lab Med 2021; 59: 1735–44.
23. Buchta C, Camp JV, Jovanovic J, et al. A look at the precision, sensitivity and specificity of SARS-CoV-2 RT-PCR assays through a dedicated external quality assessment round. Clin Chem Lab Med 2021; 60: e34–e37.
24. Buchta C, Camp JV, Jovanovic J, et al. Results of a SARS-CoV-2 virus genome detection external quality assessment round focusing on sensitivity of assays and pooling of samples. Clin Chem Lab Med 2022; 60: 1308–12
25. Edson DC, Casey DL, Harmer SE, Downes FP. Identification of SARS-CoV-2 in a Proficiency Testing Program. Am J Clin Pathol 2020; 154: 475–8.
26. Fischer C, Mögling R, Melidou A, et al. Variable Sensitivity of SARS-CoV-2 Molecular Detection in European Expert Laboratories: External Quality Assessment, June and July 2020. J Clin Microbiol 2021; 59: e02676–20.
27. Görzer I, Buchta C, Chiba P, et al. First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences. J Clin Virol 2020; 129: 104537.
28. Guo Y, Li T, Liu S, et al. External Quality Assessment for Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detection in Chongqing, China. Clin Lab 2022; 68: 171–78.
29. Ishii Y, Aoki K, Oda M, et al. A study of quality assessment in SARS-CoV-2 pathogen nucleic acid amplification tests performance; from the results of external quality assessment survey of clinical laboratories in the Tokyo Metropolitan Government external quality assessment program in 2020. J Infect Chemother 2022; 28: 242–7.
30. Kaur H, Mukhopadhyay L, Gupta N, et al. External quality assessment of COVID-19 real time reverse transcription PCR laboratories in India. PLoS One 2022; 17: e0263736.
31. Lau KA, Kaufer A, Gray J, Theis T, Rawlinson WD. Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories. Pathology 2022; 54: 615–22
32. Li RH, Wang QY. A localized small-scale external quality assessment (EQA) for PCR testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the molecular laboratories. J Virol Methods 2022; 301: 114441.
33. Matheeussen V, Corman VM, Donoso Mantke O, et al. International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020. Euro Surveill 2020; 25: 2001223.
34. Park K, Sung H, Chun S, Min WK. Evaluation of Intra- and Interlaboratory Variations in SARS-CoV-2 Real-Time RT-PCR Through Nationwide Proficiency Testing. Lab Med 2022; lmac052.
35. Sung H, Han MG, Yoo CK, et al. Nationwide External Quality Assessment of SARS-CoV-2 Molecular Testing, South Korea. Emerg Infect Dis 2020; 26: 2353–60.
36. Wang Z, Chen Y, Yang J, et al. External Quality Assessment for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Clinical Laboratories. J Mol Diagn 2021; 23: 19–28.
37. Zeichhardt H, Kammel M. INSTAND Report on Extra EQAS Group No. 340 Virus Genome Detection SARS-CoV-2 April 2020. EQA report RV-Online, report available upon request at [email protected]: INSTAND; 2020.
38. https://www.who.int/publications/i/item/WHO-2019-nCoV-Essential_IVDs-2021.1 (accessed September 04, 2022)
39. Bohn MK, Mancini N, Loh TP, et al. IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection. Clin Chem Lab Med 2020; 58: 1993–2000.
40. Richard-Greenblatt M, Ziegler MJ, Bromberg V, et al. Quantifying the Impact of Nasopharyngeal Specimen Quality on Severe Acute Respiratory Syndrome Coronavirus 2 Test Performance. Open Forum Infect Dis 2021; 8: ofab235.
41. Vierbaum L, Wojtalewicz N, Grunert H-P, Lindig V, Duehring U, Drosten C, et al. (2022) RNA reference materials with defined viral RNA loads of SARS-CoV-2—A useful tool towards a better PCR assay harmonization. PLoS ONE; 17: e0262656.
42. Assessment of EQA results for the diagnostic laboratories and the non-specialist public ("Aussagekraft und Bedeutung von Ringversuchen zum Nachweis von SARS-CoV-2. Hier: INSTAND-Ringversuch zum „Virusgenom-Nachweis - SARS-CoV-2“ im April 2020: Beurteilung der PCR-Ergebnisse") Link to be added.
43. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Laborkapazitaeten.pdf?__blob=publicationFile (accessed September 04, 2022)
44. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Vorl_Testung_nCoV.html (accessed September 04, 2022)
45. https://www.un.org/en/observances/epidemic-preparedness-day (accessed September 04, 2022)
46. United Nations General Assembly, Resolution 75.27 adopted on 7 December 2020
47. Evans D, Cowen S, Kammel M, et al. The dangers of using Cq to quantify nucleic acid in biological samples; a lesson from COVID-19. Clin Chem 2021; 68: 153–62.
48. https://www.aacc.org/science-and-research/covid-19-resources/statements-on-covid-19-testing/aacc-recommendation-for-reporting-sars-cov-2-cycle-threshold-ct-values (accessed September 04, 2022)
49. International Organization for Standardization. Medical laboratories – Requirements for quality and competence (ISO 15189:2012). International Organization for Standardization (ISO), Geneva, 2012.
50. Camp JV, Buchta C, Jovanovic J, et al. RT-PCR based SARS-CoV-2 variant screening assays require careful quality control. J Clin Virol 2021; 141: 104905.
51. Buchta C, Camp JV, Jovanovic J, et al. Inadequate design of mutation detection panels prevents interpretation of variants of concern: results of an external quality assessment for SARS-CoV-2 variant detection. Clin Chem Lab Med 2021; 60: 291–8.
52. Mulu A, Alemayehu DH, Alemu F, et al. Evaluation of sample pooling for screening of SARS CoV-2. PLoS One 2021; 16: e0247767.
53. Torres I, Albert E, Navarro D. Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR. J Med Virol 2020; 92: 2306–7.
54. https://data.worldbank.org/?locations=IN-XN (accessed September 04, 2022)